← Leaderboards
Lloyd Patrick Johnston
Selecta Biosciences, Inc.
$11,030,507
Attributed
$11,030,507
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.7M · FY2010–16$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$11,030,507 · 2
By mechanism
U01$8,033,899 · 1
RC3$2,996,608 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsDendritic CellsCessation Of LifeClinical ResearchCd4 Positive T LymphocytesCytokineB-LymphocytesBlood - Brain Barrier AnatomyBrainChemistryAgreementAntigen-Presenting CellsAntigensAdverse EventAnimalsAdjuvantBaseAntibodiesAgonistBiocompatible PolymerAddictionBolus InfusionBloodDensity
Grant awards (4)
Preclinical Development and Clinical Proof of Concept of a Synthetic Nanoparticle$2,035,915
U01 · FY2016 · DA · contact PI
Preclinical Development and Clinical Proof of Concept of a Synthetic Nanoparticle$3,748,514
U01 · FY2015 · DA · contact PI
Preclinical Development and Clinical Proof of Concept of a Synthetic Nanoparticle$2,249,470
U01 · FY2014 · DA · contact PI
Development of a Next Generation Vaccine for Smoking Cessation and Relapse Preven$2,996,608
RC3 · FY2010 · DA · contact PI